The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival, safety, and response duration results of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) in a phase I trial in patients with previously treated metastatic renal cell carcinoma (mRCC): Long-term patient follow-up.
Charles G. Drake
Consultant or Advisory Role - Bristol-Myers Squibb
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb
Mario Sznol
Consultant or Advisory Role - Bristol-Myers Squibb
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Bayer/Onyx; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Pfizer
Harriet M. Kluger
No relevant relationships to disclose
John D. Powderly
Employment or Leadership Position - BioCytics
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb; Roche/Genentech
Stock Ownership - BioCytics
Honoraria - Bristol-Myers Squibb; Dendreon; Genentech
Research Funding - Amgen; Amplimmune; Bristol-Myers Squibb; Celldex; Genentech; ImClone Systems; Lilly; Millennium; Progenics; Regeneron
David C. Smith
Research Funding - Bristol-Myers Squibb
Vindira Sankar
Employment or Leadership Position - Bristol-Myers Squibb
Andres A. Gutierrez
Employment or Leadership Position - Bristol-Myers Squibb
Jon M. Wigginton
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Georgia Kollia
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Ashok Kumar Gupta
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Michael B. Atkins
Consultant or Advisory Role - Bristol-Myers Squibb